1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Effects of Immunotherapy: new trials by email Literature Review of Effects of Immunotherapy trials Research Report on Effects of Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma Dinutuximab. Immunotherapy - Neuroblastoma, Neoplasm, Residual | Phase 2 | Completed | Fundació Sant Joan de Déu | 24 | 2014-11-26 | 2024-04-22 |
Neoplasm, Residual (1) · Neuroblastoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1) · Neuroectodermal Tumors, Primitive (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Granulocyte-Macrophage Colony-Stimulating Factor (1) · Interleukin-2 (1) · Isotretinoin (1) · dinutuximab (1) · sargramostim (1)
Spain (1)
Jaume Mora, MD (1)